Checkpoint Ev To Operating Cash Flow from 2010 to 2024

CKPT Stock  USD 3.93  0.04  1.01%   
Checkpoint Therapeutics EV To Operating Cash Flow yearly trend continues to be comparatively stable with very little volatility. EV To Operating Cash Flow will likely drop to -0.84 in 2024. EV To Operating Cash Flow is a valuation metric comparing Checkpoint Therapeutics' enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. View All Fundamentals
 
EV To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
(0.80)
Current Value
(0.84)
Quarterly Volatility
32.06359093
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Checkpoint Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Checkpoint Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 102.1 K, Depreciation And Amortization of 159.5 K or Interest Expense of 5.2 M, as well as many indicators such as Price To Sales Ratio of 438, Dividend Yield of 0.0 or Days Sales Outstanding of 168. Checkpoint financial statements analysis is a perfect complement when working with Checkpoint Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Checkpoint Therapeutics Correlation against competitors.
For more information on how to buy Checkpoint Stock please use our How to Invest in Checkpoint Therapeutics guide.

Latest Checkpoint Therapeutics' Ev To Operating Cash Flow Growth Pattern

Below is the plot of the Ev To Operating Cash Flow of Checkpoint Therapeutics over the last few years. It is a valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. Checkpoint Therapeutics' EV To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Checkpoint Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Ev To Operating Cash Flow10 Years Trend
Slightly volatile
   Ev To Operating Cash Flow   
       Timeline  

Checkpoint Ev To Operating Cash Flow Regression Statistics

Arithmetic Mean(29.22)
Coefficient Of Variation(109.72)
Mean Deviation30.19
Median(6.91)
Standard Deviation32.06
Sample Variance1,028
Range66.3786
R-Value0.87
Mean Square Error259.52
R-Squared0.77
Significance0.00002
Slope6.27
Total Sum of Squares14,393

Checkpoint Ev To Operating Cash Flow History

2024 -0.84
2023 -0.8
2022 -0.57
2021 -6.91
2020 -6.48
2019 -1.62
2018 -1.16

About Checkpoint Therapeutics Financial Statements

Checkpoint Therapeutics shareholders use historical fundamental indicators, such as Ev To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Checkpoint Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Checkpoint Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Checkpoint Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EV To Operating Cash Flow(0.80)(0.84)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Checkpoint Stock Analysis

When running Checkpoint Therapeutics' price analysis, check to measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.